Somahlution

Jupiter, United States Founded: 2010 • Age: 16 yrs Acquired By Marizyme
Therapeutics for Vascular graft disease

About Somahlution

Somahlution is a company based in Jupiter (United States) founded in 2010 was acquired by Marizyme in September 2020.. The company has 15 employees as of December 31, 2019. Somahlution operates in a competitive market with competitors including Tenaya Therapeutics, Portola Pharma, MyoKardia, Cellino and Arrakis Therapeutics, among others.

  • Headquarter Jupiter, United States
  • Employees 15 as on 31 Dec, 2019
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Somahlution, Llc
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    15

    as on Dec 31, 2019

  • Acquired by
    Marizyme

    (Sep 29, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Somahlution

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Somahlution

Somahlution has secured backing from 1 investor. Prominent investors backing the company include Marizyme. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Therapies for chronic wounds, thrombolysis, and dental health are developed.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Somahlution

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Somahlution

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Somahlution Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Somahlution

Somahlution operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tenaya Therapeutics, Portola Pharma, MyoKardia, Cellino and Arrakis Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Regenerative and gene therapeutics for heart failure are developed.
domain founded_year HQ Location
Therapeutics for cardiovascular and autoimmune diseases are developed.
domain founded_year HQ Location
Specialized drugs are developed for genetic heart diseases.
domain founded_year HQ Location
Developer of autologous cell therapies
domain founded_year HQ Location
Provider of tools for the analysis of RNA structures
domain founded_year HQ Location
Innovative pharmaceuticals for cardiovascular and metabolic diseases are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Somahlution

Frequently Asked Questions about Somahlution

When was Somahlution founded?

Somahlution was founded in 2010.

Where is Somahlution located?

Somahlution is headquartered in Jupiter, United States. It is registered at Jupiter, Florida, United States.

How many employees does Somahlution have?

As of Dec 31, 2019, the latest employee count at Somahlution is 15.

What does Somahlution do?

Somahlution was founded in 2010 and is based in Jupiter, United States. Therapeutics targeting vascular graft disease are developed within the medical biotechnology sector. An endothelial damage inhibitor has been created using GALA graft technology, functioning as an antioxidant to mitigate endothelium damage from vascular grafts. Operations center on intraoperative solutions, with this product noted as the first FDA-approved inhibitor of its kind.

Who are the top competitors of Somahlution?

Somahlution's top competitors include Esperion Therapeutics, Tenaya Therapeutics and Cellino.

Who are Somahlution's investors?

Somahlution has 1 investor. Key investors include Marizyme.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available